InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Discover the detailed record of transactions filed by Presidio Management Group X LLC. Director active across 1 companies, notably eFFECTOR Therapeutics, Inc.. Aggregated, 15 filings have been published. Total volume traded: €1.5m. The latest transaction was disclosed on 17 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations15 total
€18,90611,402 shares@ €1.65821.3% of flow
Common Stock
SEC:0001062993-22-013050:0·
€20,19310,464 shares@ €1.92981.4% of flow
Common Stock
SEC:0001062993-22-012659:0·
€9,3033,876 shares@ €2.40020.6% of flow
Common Stock
SEC:0001062993-22-012169:0·
€39,4467,861 shares@ €5.01795.5% of flow
Common Stock
SEC:0001062993-21-012276·
€39,4467,861 shares@ €5.01792.7% of flow
Common Stock
SEC:0001062993-21-012276:0·
€148,00124,965 shares@ €5.928420.8% of flow
Common Stock
SEC:0001062993-21-011920·
€148,00124,965 shares@ €5.928410.1% of flow
Common Stock
SEC:0001062993-21-011920:0·
€94,94314,418 shares@ €6.58513.3% of flow
Common Stock
SEC:0001062993-21-011704·
€94,94314,418 shares@ €6.5856.5% of flow
Common Stock
SEC:0001062993-21-011704:0·
€122,22716,226 shares@ €7.532817.2% of flow
Common Stock
SEC:0001062993-21-011394·
€122,22716,226 shares@ €7.53288.3% of flow
Common Stock
SEC:0001062993-21-011394:0·
€42,1374,914 shares@ €8.57485.9% of flow
Common Stock
SEC:0001062993-21-011097·
€42,1374,914 shares@ €8.57482.9% of flow
Common Stock
SEC:0001062993-21-011097:0·
€264,78327,892 shares@ €9.493237.2% of flow
Common Stock
SEC:0001062993-21-010758·
€264,78327,892 shares@ €9.493218.0% of flow
Common Stock
SEC:0001062993-21-010758:0·
15 of 15 declarations
About Presidio Management Group X LLC
Presidio Management Group X LLC is a significant shareholder of eFFECTOR Therapeutics, Inc.
